Neuroblastoma (NB) is a very common malignant solid tumor in childhood. NB belongs to the small round cell tumors (SRCTs), which include other solid tumors such as Ewing's sarcoma (ES), rhabdomyosarcoma, and malignant lymphoma.
NB is also characterized by elevated levels of catecholamine production. Tyrosine hydroxylase (TH) is very important as the first and rate-limiting step in the synthesis of catecholamines. [3] [4] [5] [6] Therefore, we used reverse transcription polymerase chain reaction (RT-PCR) to examine the expression of TH mRNA in some cell lines, SRCTs, and other clinical tumor samples, to assess whether we can use it as a tumor marker and detect cell contamination in hematopoietic stem cells. Specific TH mRNA could be detected in NB cell lines and clinical NB tumor samples, but not in other cell lines and tumor samples. Moreover, the technique had a high sensitivity of 1/10 5 .
We think that this method should be used for detecting minimal residual disease because the prognoses of patients in NBs depend on being positive or negative for TH mRNA in bone marrow (BM) samples within 4 months after chemotherapy. 7) Moreover, the risk of relapse after autologous peripheral blood stem cell (PBSC) or BM transplantation is high if there is NB cell contamination. 8, 9) Here, we describe a very useful method for detecting minimal residual disease. The method can also be used as a tumor marker. Three NB cell lines  (IMR-32 , 10, 12) SK-N-SH, 11, 12) and NB-39, 12) two ES cell lines (NCR-EW2, 13) SCMC-ES1 14) ), and one breast cancer cell line (MCF-7 15) ) were examined. They were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2 g/l sodium bicarbonate under 5% CO 2 at 37°C. Thirty-three clinical tumor samples (25 NBs, 1 ES, 1 osteosarcoma, 1 osteochondroma, 1 Wilms' tumor, 1 malignant lymphoma, and 3 rhabdomyosarcoma) were examined. One of the three rhabdomyosarcoma samples was from a recurrent tumor. These tissues had been stored at Ϫ80°C since collection. The clinical diagnoses for these patients were made by histopathology. Informed consent was obtained from all patients before they entered this study.
MATERIALS AND METHODS

Cell Lines and Tumor Samples
RNA Extraction Total RNA was extracted from the six cell lines using the acid-guanidium-phenol chloroform method after treatment with Catrimox-14 TM . Total RNA from the 33 clinical tumor samples was extracted by TRIZOL reagent (GIBCO BAL) based on the acid-guanidium-phenol chloroform extraction method. 16) Reverse Transcription Polymerase Chain Reaction Total RNA (1 mg) was reverse-transcribed in a 10 ml reaction mixture with a first strand cDNA synthesis kit (Rever Tra-a-TM, TOYOBO). RT was performed with Oligo-dT. The mixture was annealing at 42°C for 20 min, followed by incubated at 99°C for 5 min, and then held at 4°C. PCR amplification was carried out in 10ϫ reaction mixture containing 1.2 pmol of the respective primers. We used a HOT START PCR kit from KOD-Plus-(TOYOBO). [17] [18] [19] The PCR conditions were one cycle of template denaturing at 94°C for Neuroblastoma (NB) is the most common malignant solid tumor in childhood and, among all childhood malignancies, is second only to leukemia. NB originates before birth in the neural crest, which develops into the adrenal medullae and sympathetic ganglia. In the adrenal medulla, tyrosine hydroxylase (TH) is the first enzyme in the pathway of catecholamine synthesis. We used reverse transcription polymerase chain reaction (RT-PCR) to examine the expression of TH mRNA in NB and Ewing's sarcoma cell lines, small round cell tumors (SRCTs) containing NB, and other clinical tumor samples (osteosarcoma, osteochondroma, and Wilms' tumor). In total, we analyzed 33 clinical tumor samples. TH mRNA was expressed in all three NB cell lines examined, but not in two ES cell lines or in a breast cancer cell line. We detected TH mRNA in 23 of 25 NB tumor samples (92%), but in none of the SRCTs or other clinical tumor samples. This RT-PCR technique showed a sensitivity for TH mRNA of one NB cell per 10 5 negative cells. Based on these results, the detection of TH mRNA is very useful both as a tumor marker for NB and for detecting minimal residual disease. Therefore, we can use this method to detect tumor cell contamination before hematopoietic stem cell transplantation.
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2 min, followed by 28 cycles of denaturing at 94°C for 15 s, annealing at 60°C for 90 s, extension at 68°C for 20 s, and then holding at 4°C. We used glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal marker and IMR-32, NB-39, and SK-N-SH neuroblastoma cell lines as positive controls. NCR-EW2, SCMC-ES1, and MCF-7 were examined as negative controls. The primer sequences are listed in Table 1. 20) The primers for TH are located in exons that are not affected by alternative splicing. To avoid contamination with genomic DNA, the reverse primers for both TH and GAPDH were located in successive exons.
Analyses of PCR Products The PCR products were electrophoresed through 2.0% agarose gel, stained with ethidium bromide (WAKO), and visualized under a UV lamp. We used a Bioanalyzer (Agilent Technologies) to accurately determine band sizes.
Detection for Sensitivity A NB cell line (IMR-32) was examined as a positive control and an ES cell line (NCR-EW2) as a negative control. We counted the number of each cell type and diluted them to make suspensions containing one NB cell per 10 ES cells, one per 10 
RESULTS AND DISCUSSION
We analyzed six cell lines for detecting a specific TH mRNA with the RT-PCR technique. The electrophoresis and Bioanalyzer results are presented in Figs. 1A and 1B. The band size for TH was 299 bp, and the internal marker GAPDH was 209 bp. TH mRNA was detected in three NB cell lines (IMR-32, NB-39, and SK-N-SH), but it was not detected in the ES cell lines (NCR-EW2, SCMC-ES1) or the breast cancer cell line (MCF-7).
We investigated 33 clinical tumor samples by the same method as that used for the cell lines. The electrophoresis and Bioanalyzer results are presented in Tables 2 and 3 . In 23 of 25 NB tumor samples (92%), TH mRNA could be detected, but it was not detected in the T1 and T2 samples ( Table 2) . TH mRNA was not detected in the osteosarcoma (T26), osteochondroma (T27), Wilms' tumor (T28), and SRCT (T29-T33) samples (Table 3 ). The rhabdomyosarcoma from a recurrent tumor (T33) also did not express TH mRNA.
We examined the sensitivity for detecting minimal residual disease by this RT-PCR technique. We used a NB cell line (IMR-32) as a positive control and an ES cell line (NCR-EW2) as a negative control. The electrophoresis and Bioanalyzer results are presented in Figs. 2A and 2B . On the electrophoresis, a TH mRNA band could be seen in samples with concentrations down to one NB cell per 10 5 ES cells, but not at a concentration of one NB cell per 10 6 ES cells (Fig. 2A) .
Similarly, using the Bioanalyzer, TH mRNA could be detected at one NB cell per 10 5 ES cells but not at one NB cell per 10 6 ES cells (Fig. 2B) . Abnormal amplification and expression are well known for MYCN, [21] [22] [23] trk-A, [24] [25] [26] [27] and protein gene product 9.5 (PGP9.5) 28) in NB. However, these markers are not very useful for diagnosis. Recently, by using monoclonal antibodies 316 Vol. 27, No. 3 TH sense  5Ј-TGT CAG AGC TGG ACA AGT GT-3Ј  Exon 8  TH anti-sense  5Ј-GAT ATT GTC TTC CCG GTA GC-3Ј  Exon 9  GAPDH sense  5Ј-TCC TCT GAC TTC AAC AGC GAC ACC-3Ј  Exon 5  GAPDH anti-sense  5Ј-TCT CTC TTC CTC TTG TGC TCT TGG-3Ј  Exon 8   Table 2 . NB Patients' Clinical Profile and TH mRNA Bands Detected by Electrophoresis and Bioanalyzer that react selectively to cells of neuroectodermal origin, the diagnostic usefulness has been improved. However, the monoclonal antibodies often produce false positive results, 29, 30) and the clinical importance of detecting positive cells as evidence of infiltration is still debated. 31) As NB has a specific catecholamine metabolism, it may be more useful to detect TH, which is the first and rate-limiting enzyme of catecholamine synthesis. We found that TH mRNA was expressed in all NB cell lines (100%) and in 23 of 25 (92%) clinical NB tumor samples. On the other hand, it was not expressed in any of the other cell lines and clinical tumor samples.
Thus, we found that TH mRNA is expressed specifically in NB, and this specific expression can be use to distinguish NB from SRCTs. TH mRNA can also be used as a tumor marker for the accurate diagnosis of NB.
The expression of TH mRNA did not correlate with the patient's age or sex, and it might not be a prognostic factor for NB patients.
Another important problem is determining whether tumor cell contamination exists when a patient's PBSC or BM is used for autologous transplantation. Our method can detect contamination of one cell in 10 5 . In future, our method may be very useful for diagnosing NB patients and detecting minimal residual disease in clinical samples. Diagnosis  TH mRNA   T26  M  13 y  OS  -T27  F  12 y  OC  -T28  M  8 m  WT  -T29  F  6 m  ML  -T30  M  3 y  ES  -T31  M  11 y  RMS  -T32  F  3 y  RMS  -T33  M  4 y  RMS  - OS: osteosarcoma, OC: osteochondroma, WT: Wilms' tumor, ML: malignant lymphoma, ES: Ewing's sarcoma, RMS: rhabdomyosarcoma.
